NanoBio Corp. plans to invest $12 Million
19 February 2009NanoBio Corp. is engaged in the development of various pharmaceutical products including dermatological products that has been manufactured from NanoStat technology. The major products from the company are used for treating cold sores (herpes), acne, cystic fibrosis, intranasal problems and nail fungus (onychomycosis). The company is primarily owned and is located at Ann Arbor, Michigan.
The company NanoBio Corp. has recently got $12 million from its investors and it is part of the series B funding and will be utilized for NanoStat technology platform. So far the company has invested more than $80 million for funding company’s Nanostat technology. Majority of the support comes from Perseus LLC and other investors.
The company has already developed many novel products and pre-clinical data on some of the products shows their superiority over conventional products. The new nano-emulsion technology used for treating cystic fibrosis is found to even kill highly resistant bacteria, which would haveotherwise been alive in presence of available products in the market. Similarly the intranasal vaccines is far better than currently approved vaccines available in the market.
Related Posts:
- Johns Hopkins plan for third annual symposium on NanoBio technology
- Nanotechnology helps in producing biodiesel from algae
- Production of new innovative Li-ion batteries
- Nanotechnology programs in Finland
- Euro 22 million to be invested in Carbon Nanotube Plant
- Energy Frontier Research Centers get funding of $377 million
- Science and Technology Committee on Investment in Nanotechnology in UK
- NIST awarded new grants of $123 Million
- New Federal Funding for ONAMI
- Nanotechnology Offers Health Benefits for Developing Nations
Top Of Page | Trackback
If you found this page useful, consider linking to it. Simply copy and paste the code below into your web site.
It will look like this: NanoBio Corp. plans to invest $12 Million
